NCT00974311 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 800
- group Id
- BG001
- value
- 399
- group Id
- BG002
- value
- 1199
- units
- Participants
- groups
- description
- In DB Phase, participants received Enzalutamide capsules 160 mg orally per day. Participants who completed DB Phase, entered in optional OLE Phase and received same treatment until unacceptable toxicity, confirmed disease progression and the participant was scheduled to initiate a new systemic anti-neoplastic therapy, death or withdrawal (median treatment duration was 8.3 months).
- id
- BG000
- title
- Enzalutamide
- description
- In DB Phase, participants received placebo capsules (for Enzalutamide) orally per day. Participants who completed DB Phase, entered in optional OLE Phase and received Enzalutamide capsules 160 mg orally per day until unacceptable toxicity, confirmed disease progression and the participant was scheduled to initiate a new systemic anti-neoplastic therapy, death or withdrawal (median treatment duration was 3.0 months in DB Phase and 7.7 months in OLE Phase).
- id
- BG001
- title
- Placebo
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 232
- group Id
- BG001
- value
- 130
- group Id
- BG002
- value
- 362
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 568
- group Id
- BG001
- value
- 269
- group Id
- BG002
- value
- 837
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 7.96
- value
- 68.8
- group Id
- BG001
- spread
- 8.39
- value
- 68.6
- group Id
- BG002
- spread
- 8.11
- value
- 68.7
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Female
- measurements
- group Id
- BG000
- value
- 800
- group Id
- BG001
- value
- 399
- group Id
- BG002
- value
- 1199
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 32
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 55
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 768
- group Id
- BG001
- value
- 376
- group Id
- BG002
- value
- 1144
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 13
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 20
- group Id
- BG002
- value
- 47
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 745
- group Id
- BG001
- value
- 366
- group Id
- BG002
- value
- 1111
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 25
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 181
- group Id
- BG001
- value
- 107
- group Id
- BG002
- value
- 288
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 36
- title
- Spain
- categories
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 25
- title
- Austria
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 11
- title
- Chile
- categories
- measurements
- group Id
- BG000
- value
- 82
- group Id
- BG001
- value
- 50
- group Id
- BG002
- value
- 132
- title
- United Kingdom
- categories
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 30
- title
- Italy
- categories
- measurements
- group Id
- BG000
- value
- 193
- group Id
- BG001
- value
- 80
- group Id
- BG002
- value
- 273
- title
- France
- categories
- measurements
- group Id
- BG000
- value
- 82
- group Id
- BG001
- value
- 25
- group Id
- BG002
- value
- 107
- title
- Canada
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 10
- title
- Argentina
- categories
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 18
- group Id
- BG002
- value
- 45
- title
- Belgium
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 11
- title
- Poland
- categories
- measurements
- group Id
- BG000
- value
- 60
- group Id
- BG001
- value
- 33
- group Id
- BG002
- value
- 93
- title
- Australia
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
- population Description
- Intent-to-treat population (ITT) included all participants who were randomized into the study.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 800
- group Id
- BG001
- value
- 399
- group Id
- BG002
- value
- 1199
- units
- Participants
- groups
- description
- In DB Phase, participants received Enzalutamide capsules 160 mg orally per day. Participants who completed DB Phase, entered in optional OLE Phase and received same treatment until unacceptable toxicity, confirmed disease progression and the participant was scheduled to initiate a new systemic anti-neoplastic therapy, death or withdrawal (median treatment duration was 8.3 months).
- id
- BG000
- title
- Enzalutamide
- description
- In DB Phase, participants received placebo capsules (for Enzalutamide) orally per day. Participants who completed DB Phase, entered in optional OLE Phase and received Enzalutamide capsules 160 mg orally per day until unacceptable toxicity, confirmed disease progression and the participant was scheduled to initiate a new systemic anti-neoplastic therapy, death or withdrawal (median treatment duration was 3.0 months in DB Phase and 7.7 months in OLE Phase).
- id
- BG001
- title
- Placebo
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 232
- group Id
- BG001
- value
- 130
- group Id
- BG002
- value
- 362
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 568
- group Id
- BG001
- value
- 269
- group Id
- BG002
- value
- 837
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 7.96
- value
- 68.8
- group Id
- BG001
- spread
- 8.39
- value
- 68.6
- group Id
- BG002
- spread
- 8.11
- value
- 68.7
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Female
- measurements
- group Id
- BG000
- value
- 800
- group Id
- BG001
- value
- 399
- group Id
- BG002
- value
- 1199
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 32
- group Id
- BG001
- value
- 23
- group Id
- BG002
- value
- 55
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 768
- group Id
- BG001
- value
- 376
- group Id
- BG002
- value
- 1144
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 13
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 20
- group Id
- BG002
- value
- 47
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 745
- group Id
- BG001
- value
- 366
- group Id
- BG002
- value
- 1111
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 25
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 181
- group Id
- BG001
- value
- 107
- group Id
- BG002
- value
- 288
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 23
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 36
- title
- Spain
- categories
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 25
- title
- Austria
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 11
- title
- Chile
- categories
- measurements
- group Id
- BG000
- value
- 82
- group Id
- BG001
- value
- 50
- group Id
- BG002
- value
- 132
- title
- United Kingdom
- categories
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 30
- title
- Italy
- categories
- measurements
- group Id
- BG000
- value
- 193
- group Id
- BG001
- value
- 80
- group Id
- BG002
- value
- 273
- title
- France
- categories
- measurements
- group Id
- BG000
- value
- 82
- group Id
- BG001
- value
- 25
- group Id
- BG002
- value
- 107
- title
- Canada
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 10
- title
- Argentina
- categories
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 18
- group Id
- BG002
- value
- 45
- title
- Belgium
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 11
- title
- Poland
- categories
- measurements
- group Id
- BG000
- value
- 60
- group Id
- BG001
- value
- 33
- group Id
- BG002
- value
- 93
- title
- Australia
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
- population Description
- Intent-to-treat population (ITT) included all participants who were randomized into the study.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle